 MALVERN, Pa., Dec. 06, 2022 GLOBE NEWSWIRE Baudax Bio, Inc. the Company or Baudax Bio NASDAQ: BXRX, a pharmaceutical company focused on innovative products for hospital and related settings, today announced the closing of its previously announced public offering of an aggregate of 1,042,787 shares of its common stock or pre-funded warrants in lieu ... The post Baudax Bio Announces Closing of 5 Million Public Offering appeared first on ForexTV... 